An investigation carried out by Park et al. [17] demonstrates that lovastatin-induced death of PC3 human androgen-refractory prostate cancer cells occurs via abating transcription factor E2F-1 and its downstream signaling molecules such as c-Myc, cyclin D1, cyclin A, and cyclin B1. Here, E2F1 is linked to prostate carcinoma.